Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL

Enrollment

518

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

March 31, 2006

Conditions

Schizophrenia

Interventions

DRUG

Paliperidone palmitate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00101634 - Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter